147 related articles for article (PubMed ID: 26198942)
1. [Quantitative assessment of vasculature with DCE-MRI in nasopharyngeal carcinomas following radiotherapy and its value for efficacy evaluation].
Liao W; Yang L; Jiang W; Sun L; Cao Y; Wang X
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jul; 35(7):954-9. PubMed ID: 26198942
[TBL] [Abstract][Full Text] [Related]
2. DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas.
Liao WH; Yang LF; Liu XY; Zhou GF; Jiang WZ; Hou BL; Sun LQ; Cao Y; Wang XY
BMC Cancer; 2014 Nov; 14():835. PubMed ID: 25407966
[TBL] [Abstract][Full Text] [Related]
3. Parotid perfusion in nasopharyngeal carcinoma patients in early-to-intermediate stage after low-dose intensity-modulated radiotherapy: evaluated by fat-saturated dynamic contrast-enhanced magnetic resonance imaging.
Cheng CC; Chiu SC; Jen YM; Chang HC; Chung HW; Liu YJ; Chiu HC; Chen CY; Huang GS; Juan CJ
Magn Reson Imaging; 2013 Oct; 31(8):1278-84. PubMed ID: 23664679
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: correlation of quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters with hypoxia-inducible factor 1α expression and tumor grade/stage.
Liu L; Hu L; Zeng Q; Peng D; Chen Z; Huang C; Liu Z; Wen Q; Zou F; Yan L
Ann Palliat Med; 2021 Feb; 10(2):2238-2253. PubMed ID: 33725777
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: a preliminary study of the correlations between quantitative parameters and clinical stage.
Zheng D; Chen Y; Chen Y; Xu L; Chen W; Yao Y; Du Z; Deng X; Chan Q
J Magn Reson Imaging; 2014 Apr; 39(4):940-8. PubMed ID: 24108569
[TBL] [Abstract][Full Text] [Related]
6. Early responses assessment of neoadjuvant chemotherapy in nasopharyngeal carcinoma by serial dynamic contrast-enhanced MR imaging.
Zheng D; Yue Q; Ren W; Liu M; Zhang X; Lin H; Lai G; Chen W; Chan Q; Chen Y
Magn Reson Imaging; 2017 Jan; 35():125-131. PubMed ID: 27587228
[TBL] [Abstract][Full Text] [Related]
7. Early response to chemoradiotherapy for nasopharyngeal carcinoma treatment: Value of dynamic contrast-enhanced 3.0 T MRI.
Zheng D; Chen Y; Liu X; Chen Y; Xu L; Ren W; Chen W; Chan Q
J Magn Reson Imaging; 2015 Jun; 41(6):1528-40. PubMed ID: 25136770
[TBL] [Abstract][Full Text] [Related]
8. Early evaluation of irradiated parotid glands with intravoxel incoherent motion MR imaging: correlation with dynamic contrast-enhanced MR imaging.
Zhou N; Chu C; Dou X; Li M; Liu S; Zhu L; Liu B; Guo T; Chen W; He J; Yan J; Zhou Z; Yang X; Liu T
BMC Cancer; 2016 Nov; 16(1):865. PubMed ID: 27821130
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
Kang SR; Kim HW; Kim HS
J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced MRI predicts PTEN protein expression which can function as a prognostic measure of progression-free survival in NPC patients.
Wu G; Huang W; Xu J; Li W; Wu Y; Yang Q; Liu K; Zhu M; Balasubramanian PS; Li M
J Cancer Res Clin Oncol; 2022 Jul; 148(7):1771-1780. PubMed ID: 34398299
[TBL] [Abstract][Full Text] [Related]
11. Quantitative dynamic contrast-enhanced magnetic resonance imaging in a VX2 rabbit liver tumour model using different gadolinium-based contrast agents: comparison of DCE-MRI quantitative results between Magnevist and Eovist.
Zhang Y; Liu H; Xiao W; Zhu L; Wang N; He X; Jiang Z; Guan B
BJR Case Rep; 2017; 3(3):20160099. PubMed ID: 30363268
[TBL] [Abstract][Full Text] [Related]
12. DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1α, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma patients.
Huang W; Zhang Q; Wu G; Chen PP; Li J; McCabe Gillen K; Spincemaille P; Chiang GC; Gupta A; Wang Y; Chen F
Radiother Oncol; 2021 Nov; 164():146-154. PubMed ID: 34592360
[TBL] [Abstract][Full Text] [Related]
13. Investigating the correlation of arterial spin labeling and dynamic contrast enhanced perfusion in primary tumor of nasopharyngeal carcinoma.
Lin M; Yu X; Luo D; Ouyang H; Xie L; Wu B; Zhou C
Eur J Radiol; 2018 Nov; 108():222-229. PubMed ID: 30396660
[TBL] [Abstract][Full Text] [Related]
14. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between parameters of dynamic contrast-enhanced MRI and clinical stage of nasopharyngeal carcinoma].
Yu X; Li F; Hu Y; Lu Q; Wang H
Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):597-602. PubMed ID: 26714600
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment Dynamic Contrast-Enhanced MRI Improves Prediction of Early Distant Metastases in Patients With Nasopharyngeal Carcinoma.
Chin SC; Lin CY; Huang BS; Tsang NM; Fan KH; Ku YK; Hsu CL; Chan SC; Huang SF; Li CH; Tseng HJ; Liao CT; Liu HL; Sung K
Medicine (Baltimore); 2016 Feb; 95(6):e2567. PubMed ID: 26871776
[TBL] [Abstract][Full Text] [Related]
17. Value of dynamic contrast-enhanced magnetic resonance imaging for determining the plasma Epstein-Barr virus status and staging of nasopharyngeal carcinoma.
Sriyook A; Lertbutsayanukul C; Jittapiromsak N
Clin Imaging; 2021 Apr; 72():1-7. PubMed ID: 33190027
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of the Pretreatment Primary Lesion Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Nasopharyngeal Carcinoma.
Qin Y; Yu X; Hou J; Hu Y; Li F; Wen L; Lu Q; Liu S
Acad Radiol; 2019 Nov; 26(11):1473-1482. PubMed ID: 30772137
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model.
Ceelen W; Smeets P; Backes W; Van Damme N; Boterberg T; Demetter P; Bouckenooghe I; De Visschere M; Peeters M; Pattyn P
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1188-96. PubMed ID: 16457965
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma: comparison of semiquantitative and quantitative parameters and correlation with tumour stage.
Huang B; Wong CS; Whitcher B; Kwong DL; Lai V; Chan Q; Khong PL
Eur Radiol; 2013 Jun; 23(6):1495-502. PubMed ID: 23377545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
